000952 广济药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-9.584-24.320-9.7873.3957.766
总资产报酬率 ROA (%)-3.621-10.142-5.1002.2285.467
投入资产回报率 ROIC (%)-3.990-11.454-5.7542.4676.066

边际利润分析
销售毛利率 (%)29.39718.73827.40536.99838.347
营业利润率 (%)-24.463-49.764-19.1187.62015.046
息税前利润/营业总收入 (%)-16.623-41.376-13.1339.44017.838
净利润/营业总收入 (%)-24.933-49.332-20.6575.97813.469

收益指标分析
经营活动净收益/利润总额(%)115.07884.83588.74779.03164.450
价值变动净收益/利润总额(%)-17.5728.7177.12610.49015.058
营业外收支净额/利润总额(%)1.8450.749-0.275-1.1634.939

偿债能力分析
流动比率 (X)0.6710.9931.2531.5371.312
速动比率 (X)0.4120.6460.9071.1991.007
资产负债率 (%)62.67161.47654.03739.60229.191
带息债务/全部投入资本 (%)54.09641.88434.99429.15519.602
股东权益/带息债务 (%)75.541101.135147.478230.828403.704
股东权益/负债合计 (%)59.70062.00983.286153.619244.523
利息保障倍数 (X)-2.003-4.721-2.2144.9498.876

营运能力分析
应收账款周转天数 (天)100.361108.142100.44186.86665.786
存货周转天数 (天)284.803215.341174.906138.366122.049